* TAZOCIN 4g/0.500 g, lyophilized powder for intravenous infusion. For INTRAVENOUS USE only (Contains EDTA). * COMPOSITION: One vial contains: & & Piperacillin sodium (equiv. to 4 g piperacillin) 4170 mg; & & Tazobactam sodium (equiv. to 500 mg tazobactam) 536.6 mg. * Excipients: & & Citric Acid Monohydrate – Disodium Edetate Monohydrate (Ph. Eur. compliant). * WARNINGS: & & – For intravenous use only. & & – Do not administer intramuscularly. * STORAGE METHODS: & & – Lyophilized powder: The vials containing the sterile Tazocin lyophilized powder may be stored at room temperature & & (Do not store above 25 degrees C) until the expiration date printed on the box. & & – Solutions: The vials containing the reconstituted solutions for intravenous use are stable for 24 hours at room & & temperature and up to 48 hours in the refrigerator (2-8 degrees C). Unused solutions must be discarded. * Dispose of in an environmentally correct manner after use. * The expiration date indicated refers to the product in the intact package, properly stored. * Manufactured by: Wyeth Lederle S.p.A. – Catania (Italy). Imported by: Wyeth Egypt. & & Marketing Authorization Holder: Wyeth Lederle S.p.A. – Catania (Italy).